Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer.
about
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancerVersatility of Particulate Carriers: Development of Pharmacodynamically Optimized Drug-Loaded Microparticles for Treatment of Peritoneal Cancer.Peritoneal Carcinomatosis from Colon Cancer: A Systematic Review of the Data for Cytoreduction and Intraperitoneal ChemotherapyPhase II trial of adjuvant oral thalidomide following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface disease from colorectal/appendiceal cancer.Adenocarcinoma of the stomach: a review.The incidence of port-site metastases in gynecologic cancers.Oxaliplatin-based versus irinotecan-based hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastasis from appendiceal and colorectal cancer: a retrospective analysis.A prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC trialIntraperitoneal therapy for peritoneal cancer.Brief intraperitoneal radioimmunotherapy of small peritoneal carcinomatosis using high activities of noninternalizing 125I-labeled monoclonal antibodies.GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study.Cytoreductive surgery of colorectal peritoneal metastases: outcomes after complete cytoreductive surgery and systemic chemotherapy onlyMalignant ascites: A review of prognostic factors, pathophysiology and therapeutic measures.Splenectomy ameliorates hematologic toxicity of hyperthermic intraperitoneal chemotherapy.Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.The Role of Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer.The effects of hyperbaric oxygen therapy on experimental colon anastomosis after preoperative chemoradiotherapy.Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapyCurrent status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosisComparison of intravenous versus intraperitoneal administration of oncolytic herpes simplex virus 1 for peritoneal carcinomatosis in miceEffect of intraperitoneal cetuximab administration on colonic anastomosis and early postoperative adhesion formation in a rat model.Retrospective analysis on the safety of 5,759 times of bedside hyperthermic intra-peritoneal or intra-pleural chemotherapy (HIPEC)Outcomes of repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal surface malignancy.Assessment of clinical benefit and quality of life in patients undergoing cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for management of peritoneal metastasesWhat make differences in the outcome of adjuvant treatments for resected gastric cancer?Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for peritoneal carcinomatosis from colorectal cancer: a systematic review and meta-analysis of current evidence.Prognostic factors in patients with loco-regionally advanced gastric cancer.Management and Outcomes of Hospitalized Patients With Primary Neuroendocrine Tumor and Non-Neuroendocrine Tumor Appendiceal Cancers in the United States.A comparison between radioimmunotherapy and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis of colonic origin in rats.Epididymitis following Cytoreductive Surgery with Intraperitoneal Oxaliplatin Chemotherapy: Two Case Reports.Current role of hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis from colorectal cancer.Principles and Innovations in Peritoneal Surface Malignancy Treatment.Fluorescent-guided surgery for sentinel lymph node detection in gastric cancer and carcinoembryonic antigen targeted fluorescent-guided surgery in colorectal and pancreatic cancer
P2860
Q26774538-C6BDF1E8-6A06-4EAF-8FB2-E4562282FBDFQ27687617-4229FC12-6082-49C4-913C-2D00361A15C8Q31031044-D20BC125-E53B-4D39-AE77-22EA57AB901AQ33940841-A45B0F65-DCF2-46CC-93C0-283AD366E95DQ33944994-8AD886BF-CD40-4F1B-B048-0C991B1D9A52Q34464482-FA48FCF2-FB8A-4403-97DC-83E249DF787CQ34491336-F0EA365E-11D5-4DFF-9CD4-F5B230151DE5Q34580450-13E64712-92C2-4F04-9AEB-A58E3A3A4AC1Q34789701-E32A28B6-FA83-492C-968C-3595A6C7AD95Q34841141-4E303168-7293-4606-810F-CDA7DBF31693Q35120716-613253D7-DAC1-4AD9-AFCE-EB16EE69B924Q35234968-09A85EA6-8958-4A5D-BC7A-1C007579528DQ35957129-24659A5A-F9D0-4A55-91CD-37F3FFC9533DQ36097154-4F546A27-AF39-466E-A558-D84C093E6CCDQ36375924-18087AC9-F594-49C9-9454-5537A21B0832Q36758921-15CDCA74-AFED-44AD-AA85-E5610856B416Q37044738-AF587697-9EE6-49AA-AD1D-EF8B84446457Q37090867-8CD75877-FDEF-4751-B62B-AD56D3D3E791Q37094755-7798FD49-9916-4739-96D7-821FDF7C1402Q37132189-76EF8022-DFE5-4D46-9402-37DBACA27179Q37146594-DFC55461-7B96-47FF-8829-8BF6FB86F300Q37225339-4DDA495C-7CB7-42C0-81D9-3545B2B5140EQ37512841-F665DFB0-F3A0-4E0F-AF69-F1EF96843DECQ38085569-A02C4E7A-C68D-402B-899B-19EE93C98A9CQ38247980-11FFB9E4-A125-4495-8038-81E93D554AADQ41547533-6F5FA1DD-9537-4057-B7ED-9597D43ED2B1Q41718964-624F390F-37A3-43E7-93E3-08ED7513CC03Q42286720-50DE37E6-ED51-4A58-B7B6-9E88792EAD14Q42609788-33AEE892-6193-47C3-9D2A-60AF16AF689CQ42736470-2315E0CF-0BC6-4975-A4DC-63822C86578CQ42863985-C69C33BF-8B0E-45AC-99C5-C2CD85C59FE8Q47166165-DC3A1B68-D22D-4C2F-ADF5-9DD0EB517165Q58738334-3657803C-0DCE-4B8A-A8CA-D430A5A8A225
P2860
Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Rationale for integrating earl ...... nt of gastrointestinal cancer.
@en
type
label
Rationale for integrating earl ...... nt of gastrointestinal cancer.
@en
prefLabel
Rationale for integrating earl ...... nt of gastrointestinal cancer.
@en
P2093
P1433
P1476
Rationale for integrating earl ...... ent of gastrointestinal cancer
@en
P2093
Belliveau J
Cunliffe WJ
Mullins RE
Sugarbaker PH
de Bruijn EA
P433
P577
1989-08-01T00:00:00Z